Resveratrol inhibits proliferation and promotes apoptosis of keloid fibroblasts by targeting HIF-1α

References

• Werner S, Krieg T, Smola H. Keratinocyte–fibroblast interactions in wound healing. J Invest Dermatol. 2007;127(5):998–1008.
   PubMed Web of Science ®Google Scholar
• Botwood N, Lewanski C, Lowdell C. The risks of treating keloids with radiotherapy. Br J Radiol. 1999;72(864):1222–1224.
   PubMed Web of Science ®Google Scholar
• Tuan T, Nichter L. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today. 1998;4(1):19–24.
   PubMedGoogle Scholar
• Andrews J, Marttala J, Macarak E, et al. Keloids: the paradigm of skin fibrosis—pathomechanisms and treatment. Matrix Biol. 2016;51:37–46.
   PubMed Web of Science ®Google Scholar
• Shang Y, Yu D, Hao L. Liposome-adenoviral hTERT-siRNA knockdown in fibroblasts from keloids reduce telomere length and fibroblast growth. Cell Biochem Biophys. 2015;72(2):405–410.
   PubMed Web of Science ®Google Scholar
• Sidgwick G, Bayat A. Extracellular matrix molecules implicated in hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol. 2012;26(2):141–152.
   PubMed Web of Science ®Google Scholar
• Aoki M, Miyake K, Ogawa R, et al. siRNA knockdown of tissue inhibitor of metalloproteinase-1 in keloid fibroblasts leads to degradation of collagen type I. J Invest Dermatol. 2014;134(3):818–826.
   PubMed Web of Science ®Google Scholar
• Gragnani A, Warde M, Furtado F, et al. Topical tamoxifen therapy in hypertrophic scars or keloids in burns. Arch Dermatol Res. 2010;302(1):1–4.
   PubMed Web of Science ®Google Scholar
• Nanda S, Reddy B. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg. 2004;30(1):54–56.
   PubMed Web of Science ®Google Scholar
• Sooriakumaran P, Kaba R. Angiogenesis and the tumour hypoxia response in prostate cancer: a review. Int J Surg. 2005;3(1):61–67.
   PubMedGoogle Scholar
• Selvendiran K, Bratasz A, Kuppusamy M, et al. Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. Int J Cancer. 2009;125(9):2198–2204.
   PubMed Web of Science ®Google Scholar
• Jensen R. Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol. 2009;92(3):317–335.
   PubMed Web of Science ®Google Scholar
• Higgins L, Withers H, Garbens A, et al. Hypoxia and the metabolic phenotype of prostate cancer cells. Biochim Biophys Acta. 2009;1787(12):1433–1443.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Briest S, Höckel M. Hypoxia in breast cancer: pathogenesis, characterization and biological/therapeutic implications. Wien Med Wochenschr. 2002;152(13–14):334–342.
   PubMedGoogle Scholar
• Majmundar A, Wong W, Simon M. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell. 2010;40(2):294–309.
   PubMed Web of Science ®Google Scholar
• Csiszar A, Labinskyy N, Olson S, et al. Resveratrol prevents monocrotaline-induced pulmonary hypertension in rats. Hypertension. 2009;54(3):668–675.
   PubMed Web of Science ®Google Scholar
• Chen B, Xue J, Meng X, et al. Resveratrol prevents hypoxia-induced arginase II expression and proliferation of human pulmonary artery smooth muscle cells via Akt-dependent signaling. Am J Physiol Lung Cell Mol Physiol. 2014;307(4):L317–L325.
   PubMed Web of Science ®Google Scholar
• Ikeda K, Torigoe T, Matsumoto Y, et al. Resveratrol inhibits fibrogenesis and induces apoptosis in keloid fibroblasts. Wound Repair Regen. 2013;21(4):616–623.
   PubMed Web of Science ®Google Scholar
• Zeng G, Zhong F, Li J, et al. Resveratrol mediated reduction of collagen by inhibiting proliferation and producing apoptosis in human hypertrophic scar fibroblasts. Biosci Biotechnol Biochem. 2013;77(12):2389–2396.
   PubMed Web of Science ®Google Scholar
• Hung SP, Ho JH, Shih YR, et al. Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells. J Orthop Res. 2012;30(2):260–266.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Nie F, Kang C, et al. Increased perostin expression affects the proliferation, collagen synthesis, migration and invasion of keloid fibroblasts under hypoxic conditions. Int J Mol Med. 2014;34(1):253–261.
   PubMed Web of Science ®Google Scholar
• Mehta M, Branford OA, Rolfe KJ. The evidence for natural therapeutics as potential anti-scarring agents in burn-related scarring. Burns Trauma. 2016;4:15–27.
   PubMed Web of Science ®Google Scholar
• Zhang B, Guan H, Liu JQ, et al. Hypoxia drives the transition of human dermal fibroblasts to a myofibroblast-like phenotype via the TGFβ1/Smad3 pathway. Int J Mol Med. 2017;39(1):153–159.
   PubMed Web of Science ®Google Scholar
• Athar M, Back JH, Tang X, et al. Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol. 2007;224(3):274–283.
   PubMed Web of Science ®Google Scholar
• Xu W, Zhao Y, Zhang B, et al. Resveratrol attenuates hyperoxia-induced oxidative stress, inflammation and fibrosis and suppresses Wnt/β-catenin signalling in lungs of neonatal rats. Clin Exp Pharmacol Physiol. 2015;42(10):1075–1083.
   PubMed Web of Science ®Google Scholar
• Athar M, Back JH, Kopelovich L, et al. Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms. Arch Biochem Biophys. 2009;486(2):95–102.
   PubMed Web of Science ®Google Scholar
• Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. 2011;14(5):612–622.
   PubMed Web of Science ®Google Scholar
• Crandall JP, Oram V, Trandafirescu G, et al. Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci. 2012;67(12):1307–1312.
   PubMed Web of Science ®Google Scholar
• Faber AC, Dufort FJ, Blair D, et al. Inhibition of phosphatidylinositol 3-kinase-mediated glucose metabolism coincides with resveratrol-induced cell cycle arrest in human diffuse large B-cell lymphomas. Biochem Pharmacol. 2006;72(10):1246–1256.
   PubMed Web of Science ®Google Scholar
• Massimi M, Tomassini A, Sciubba F, et al. Effects of resveratrol on HepG2 cells as revealed by (1)H-NMR based metabolic profiling. Biochim Biophys Acta. 2012;1820(1):1–8.
   PubMed Web of Science ®Google Scholar
• Lim JH, Lee YM, Chun YS, et al. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1 alpha. Mol Cell. 2010;38(6):864–878.
   PubMed Web of Science ®Google Scholar
• Mancini M, Gariboldi MB, Taiana E, et al. Co-targeting the IGF system and HIF-1 inhibits migration and invasion by (triple-negative) breast cancer cells. Br J Cancer. 2014;110(12):2865–2873.
   PubMed Web of Science ®Google Scholar
• Conde E, Alegre L, Blanco-Sánchez I, et al. Hypoxia inducible factor 1-alpha (HIF-1 alpha) is induced during reperfusion after renal ischemia and is critical for proximal tubule cell survival. PLos One. 2012;7(3):e33258.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Tang X, Lu QY, et al. Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther. 2005;4(10):1465–1474.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Oh CK, Messadi DV, et al. Hypoxia-induced HIF-1 alpha accumulation is augmented in a co-culture of keloid fibroblasts and human mast cells: involvement of ERK1/2 and PI-3K/Akt. Exp Cell Res. 2006;312(2):145–155.
   PubMed Web of Science ®Google Scholar
• Ma X, Chen J, Xu B, et al. Keloid-derived keratinocytes acquire a fibroblast-like appearance and an enhanced invasive capacity in a hypoxic microenvironment in vitro. Int J Mol Med. 2015;35(5):1246–1256.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Agarwal P. Targeting extracellular matrix remodeling in disease: could resveratrol be a potential candidate? Exp Biol Med (Maywood)). 2017;242(4):374–383.
   PubMed Web of Science ®Google Scholar
• Eisinger-Mathason T, Zhang M, Qiu Q, et al. Hypoxia-dependent modification of collagen networks promotes sarcoma metastasis. Cancer Discov. 2013;3:1990–1205.
   Web of Science ®Google Scholar
• Nasseri YY, Krott E, Groningen KMV, Berho M, et al. Abnormalities in collagen composition may contribute to the pathogenesis of hemorrhoids: morphometric analysis. Tech Coloproctol. 2015;19(2):83–87.
   PubMed Web of Science ®Google Scholar
• Cicchi R, Vogler N, Kapsokalyvas D, et al. From molecular structure to tissue architecture: collagen organization probed by SHG microscopy. J Biophoton. 2013;6(2):129–142.
   PubMed Web of Science ®Google Scholar